The authors apologize for the written mistakes in sections, Results and References. Corrections are shown below.
1) Page 576, Results section, first paragraph
Incorrect:
Table 1 shows patient characteristics at baseline in Groups 1–4. Group 4 had the highest age (70±9 years; P<0.001). There were no significant differences observed in gender, blood pressure, body mass index (BMI), smoking history, family history, cardiac ultrasound-derived ejection fraction, or blood test results including HbA1c and renal function (Cr). Similarly, there were no significant differences in past medical history or comorbidities such as hypertension, arteriosclerotic occlusive disease, or cerebrovascular accidents.
Correct:
Table 1 shows patient characteristics at baseline in Groups 1–4. Group 4 had the highest age (70±9 years; P<0.001). There were no significant differences observed in gender, blood pressure, smoking history, family history, cardiac ultrasound-derived ejection fraction, or blood test results including HbA1c. Similarly, there were no significant differences in past medical history or comorbidities such as hypertension, arteriosclerotic occlusive disease, or cerebrovascular accidents.
2) Page 582, Reference 9
Incorrect:
9. O’Brien KD, Hippe DS, Chen H, Neradilek MB, Probstfield JL, Peck S, et al. Summary of clinical and laboratory data of study subjects with and without DCE-MRI plaque measurements in the AIM-HIGH clinical trial. Data Brief 2016; 6: 476–481.
Correct:
9. Guyton JR, Slee AE, Anderson T, Fleg JL, Goldberg RB, Kashyap ML, et al. Relationship of lipoproteins to cardiovascular events: The AIM-HIGH Trial (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides and Impact on Global Health Outcomes). J Am Coll Cardiol 2013; 62: 1580–1584.
